Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
3.570
+0.490 (15.91%)
At close: May 27, 2026, 4:00 PM EDT
3.610
+0.040 (1.12%)
After-hours: May 27, 2026, 7:56 PM EDT
Editas Medicine Market Cap
Editas Medicine has a market cap or net worth of $349.53 million as of May 27, 2026. Its market cap has increased by 171.16% in one year.
Market Cap
349.53M
Enterprise Value
244.15M
1-Year Change
171.16%
Ranking
Category
Stock Price
$3.57
Market Cap Chart
Since February 3, 2016, Editas Medicine's market cap has decreased from $649.70M to $349.53M, a decrease of -46.20%. That is a compound annual growth rate of -5.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 349.50M | 74.66% |
| Dec 31, 2025 | 200.10M | 90.94% |
| Dec 31, 2024 | 104.80M | -87.33% |
| Dec 29, 2023 | 827.40M | 35.66% |
| Dec 30, 2022 | 609.90M | -66.42% |
| Dec 31, 2021 | 1.82B | -58.45% |
| Dec 31, 2020 | 4.37B | 187.69% |
| Dec 31, 2019 | 1.52B | 39.66% |
| Dec 31, 2018 | 1.09B | -15.40% |
| Dec 29, 2017 | 1.29B | 122.48% |
| Dec 30, 2016 | 577.90M | -11.05% |
| Feb 3, 2016 | 649.70M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Silence Therapeutics | 313.64M |
| Abeona Therapeutics | 313.47M |
| Nautilus Biotechnology | 308.80M |
| Niagen Bioscience | 308.07M |
| Surrozen | 303.84M |
| YD Bio | 303.08M |
| Eledon Pharmaceuticals | 300.71M |
| Armata Pharmaceuticals | 299.80M |